1371. A putative serine protease is required to initiate the RIPK3-MLKL—mediated necroptotic death pathway in neutrophilsXiaoliang Wang, Damjan Avsec, Aleš Obreza, Shida Yousefi, Irena Mlinarič-Raščan, Hans-Uwe Simon, 2021, original scientific article Keywords: necroptosis, neutrophil, serine protease, signal transduction, small molecule inhibitor Full text (file, 1,47 MB) This document has more files! More... |
1372. Inhibition of p38 MAPK or immunoproteasome overcomes resistance of chronic lymphocytic leukemia cells to Bcl-2 antagonist venetoclaxDamjan Avsec, Marja Škrlj, Tilen Burnik, Maša Kandušer, Maruša Bizjak, Helena Podgornik, Irena Mlinarič-Raščan, 2022, original scientific article Full text (file, 4,77 MB) This document has more files! More... |
1373. Vloga avtofagije pri odpornosti celic kronične limfocitne levkemije na zaviralce receptorske poti celic BŠpela Jelesijevič, 2022, master's thesis/paper Keywords: kronična limfocitna levkemija (KLL), odpornost na zdravljenje, ibrutinib, akalabrutinib, duvelizib, idelalizib, avtofagija, sinergizem Full text (file, 3,93 MB) This document has more files! More... |
|
|
1376. Sinergistično delovanje zaviralcev proteasoma in imunoproteasoma z zaviralci receptorske poti limfocitov B na celicah kronične limfocitne levkemijeTilen Burnik, 2022, master's thesis/paper Keywords: kronična limfocitna levkemija, konstitutivni proteasom, imunoproteasom, karfilzomib, ONX-0914, NFκB, sinergizem Full text (file, 2,96 MB) This document has more files! More... |
1377. Preučevanje mehanizmov odpornosti celic kronične limfocitne levkemije na sodobno terapijoAnđela Dragović, 2023, master's thesis/paper Keywords: kronična limfocitna levkemija, fosfatidilinozitol 3-kinaza, PI3K, NF-κB, idelalizib, duvelizib, proteasom, imunoproteasom, karfilzomib, ONX-0914, odpornost Full text (file, 3,33 MB) |
1378. The role of proteasome, immunoproteasome and autophagy in the therapy of chronic lymphocytic leukemiaDamjan Avsec, 2023, doctoral dissertation Keywords: CLL, proteasome, immunoproteasome, autophagy, targeted therapy, resistance, ibrutinib, idelalisib, venetoclax, NFκB, B-cell receptor Full text (file, 31,60 MB) |
|
1380. Co-crystals, salts or mixtures of both? The case of tenofovir alafenamide fumaratesHannes Lengauer, Damjan Makuc, Damjan Šterk, Franc Perdih, Arthur Pichler, Tina Trdan Lušin, Janez Plavec, Zdenko Časar, 2020, original scientific article Keywords: co-crystal, salt, polymorphism, X-ray diffraction, ssNMR, tenofovir alafenamide fumarate Full text (file, 3,70 MB) This document has more files! More... |